Wright P, Cooper M, Gilvarry A M
Br J Ophthalmol. 1987 Feb;71(2):161-4. doi: 10.1136/bjo.71.2.161.
Patients with clinically well defined keratoconjunctivitis sicca (KCS) participated in two trials of hypo-osmolar tear substitutes. The trials were double masked, single crossover studies with computer generated random order allocation and were conducted by postal questionnaire. In the first trial a hypo-osmolar formulation using polyvinylpyrrolidone and hydroxyethyl cellulose was compared with the patients' usual treatment (BJ6 or hypromellose) and found to be inferior, especially in respect of blurring and stickiness caused by higher viscosity. In the second trial hypo-osmolar preparations of BJ6 and hypromellose were compared with their iso-osmolar equivalents and found not to be significantly different in their effects. Hypo-osmolarity alone does not seem to guarantee relief of symptoms in KCS. Other factors including viscosity and colloid osmotic pressure may be more significant.
患有临床诊断明确的干燥性角结膜炎(KCS)的患者参与了两项低渗性泪液替代物试验。试验采用双盲、单交叉研究,通过计算机随机排序分配,并通过邮寄问卷进行。在第一项试验中,将使用聚乙烯吡咯烷酮和羟乙基纤维素的低渗配方与患者的常规治疗(BJ6或羟丙甲纤维素)进行比较,发现前者较差,尤其是在因较高粘度导致的视物模糊和粘性方面。在第二项试验中,将BJ6和羟丙甲纤维素的低渗制剂与其等渗等效物进行比较,发现它们的效果没有显著差异。仅低渗性似乎并不能保证缓解KCS的症状。其他因素,包括粘度和胶体渗透压,可能更重要。